(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 29640.50 | 25697.30 | 15.34 | 29640.50 | 25697.30 | 15.34 | 104211.80 | 95074.10 | 9.61 |
| Other Income | 339.60 | 652.10 | -47.92 | 339.60 | 652.10 | -47.92 | 3261.00 | 4934.20 | -33.91 |
| PBIDT | 9625.40 | 7501.40 | 28.31 | 9625.40 | 7501.40 | 28.31 | 34120.20 | 29182.40 | 16.92 |
| Interest | 949.50 | 1493.40 | -36.42 | 949.50 | 1493.40 | -36.42 | 5622.10 | 3769.80 | 49.14 |
| PBDT | 8675.90 | 6008.00 | 44.41 | 8675.90 | 6008.00 | 44.41 | 27435.70 | 25412.60 | 7.96 |
| Depreciation | 1110.20 | 1046.30 | 6.11 | 1110.20 | 1046.30 | 6.11 | 4285.70 | 3947.60 | 8.56 |
| PBT | 7565.70 | 4961.70 | 52.48 | 7565.70 | 4961.70 | 52.48 | 23150.00 | 21465.00 | 7.85 |
| TAX | 1980.80 | 809.00 | 144.85 | 1980.80 | 809.00 | 144.85 | 2774.40 | 4217.40 | -34.22 |
| Deferred Tax | 327.40 | -112.40 | -391.28 | 327.40 | -112.40 | -391.28 | -1957.80 | -481.90 | 306.27 |
| PAT | 5584.90 | 4152.70 | 34.49 | 5584.90 | 4152.70 | 34.49 | 20375.60 | 17247.60 | 18.14 |
| Equity | 413.00 | 412.70 | 0.07 | 413.00 | 412.70 | 0.07 | 412.80 | 412.60 | 0.05 |
| PBIDTM(%) | 32.47 | 29.19 | 11.24 | 32.47 | 29.19 | 11.24 | 32.74 | 30.69 | 6.67 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.00 |
| Dr. Reddys Labs. | 1198.95 |
| Cipla | 1461.55 |
| Lupin | 2264.70 |
| Zydus Lifesciences | 1204.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: